Beta Drugs Limited submitted financial results for the period ended March 31, 2024, with consolidated revenues growing 30.2% to Rs 296 crores, EBITDA at Rs 61.4 crores, net profit up 19% to Rs 36.4 crores, and guidance for FY 25 expecting revenue inc
AI Assistant
Beta Drugs Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.